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Abstract
SLC34A3/NPT2c/NaPi-2c/Npt2c is a growth-related NaPi cotransporter that medi-
ates the uptake of renal sodium-dependent phosphate (Pi). Mutation of human NPT2c 
causes hereditary hypophosphatemic rickets with hypercalciuria. Mice with Npt2c 
knockout, however, exhibit normal Pi metabolism. To investigate the role of Npt2c in 
Pi homeostasis, we generated α-klotho−/−/Npt2c−/− (KL2cDKO) mice and analyzed 
Pi homeostasis. α-Klotho−/− (KLKO) mice exhibit hyperphosphatemia and markedly 
increased kidney Npt2c protein levels. Genetic disruption of Npt2c extended the lifes-
pan of KLKO mice similar to that of α-Klotho−/−/Npt2a−/− mice. Adult KL2cDKO 
mice had hyperphosphatemia, but analysis of Pi metabolism revealed significantly 
decreased intestinal and renal Pi (re)absorption compared with KLKO mice. The 
1,25-dihydroxy vitamin D3 concentration was not reduced in KL2cDKO mice com-
pared with that in KLKO mice. The KL2cDKO mice had less severe soft tissue and 
vascular calcification compared with KLKO mice. Juvenile KL2cDKO mice had sig-
nificantly reduced plasma Pi levels, but Pi metabolism was not changed. In Npt2cKO 
mice, plasma Pi levels began to decrease around the age of 15 days and significant hy-
pophosphatemia developed within 21 days. The findings of the present study suggest 
that Npt2c contributes to regulating plasma Pi levels in the juvenile stage and affects 
Pi retention in the soft and vascular tissues in KLKO mice.
K E Y W O R D S
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1 |  INTRODUCTION
The serum inorganic phosphate (Pi) concentration is con-
trolled by the intestines and kidneys, which regulate Pi 
absorption/excretion; the bones, liver, and muscles, which 
store Pi; and regulatory factors (Kaneko, Tatsumi, Segawa, 
& Miyamoto, 2017). Sodium-dependent phosphate trans-
porters (the solute carrier 34 [SLC34] family) have an 
important role in regulating serum Pi levels. SLC34A1/
NPT2A/NaPi-2a and SLC34A3/NPT2C/NaPi-2c are 
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predominantly expressed in the proximal tubules of the 
kidney (Kaneko et al., 2011; Lederer & Miyamoto, 2012; 
Levi et al., 2019). The phenotypic differences resulting 
from NPT2A and NPT2C gene mutations may be due to 
differential dominance of the transporters involved in Pi ho-
meostasis. In humans, NPT2C mutations cause hereditary 
hypophosphatemic rickets with hypercalciuria (HHRH), a 
primary renal Pi wasting disorder that results in increased 
serum 1,25-dihydroxy vitamin D3 [1,25(OH)2D3] con-
centrations with associated intestinal Ca2+ hyperabsorp-
tion, hypercalciuria, and rickets/osteomalacia (Bergwitz & 
Miyamoto, 2019; Bergwitz et al., 2006; Lorenz-Depiereux 
et al., 2006; Yamamoto et al., 2007). In mice, disruption 
of Npt2c (Npt2 designate a mouse NaPi-2) causes hyper-
calciuria and increased serum 1,25(OH)2D3 concentrations, 
but not hypophosphatemia, rickets, or nephrocalcinosis 
(Segawa, Onitsuka, Kuwahata, et al., 2009). Furthermore, 
only Npt2a/Npt2c double knockout (KO) mice exhibit a 
physiology similar to that of patients with HHRH (Segawa, 
Onitsuka, Furutani, et al., 2009). In rodents, Npt2a is a 
major functional NaPi cotransporter in the proximal tu-
bules (Kaneko et al., 2017; Lederer & Miyamoto, 2012; 
Levi et al., 2019). Npt2c is important for Pi reabsorption 
in weanling animals but mediates a very small percentage 
of Pi reabsorption in adult animals (Segawa et al., 2002). A 
recent study demonstrated that mice with kidney-specific 
Npt2c deletion show no prominent phenotype (Myakala et 
al., 2014). The Npt2c transcript, however, was detected in 
several tissues, suggesting that extrarenal Npt2c has an im-
portant role (Kuwahara et al., 2012; Nishimura & Naito, 
2008).
Fibroblast growth factor (FGF)23 is a hormone that pro-
motes renal Pi excretion by decreasing Pi reabsorption in the 
proximal tubules while concurrently reducing the plasma 
1,25(OH)2D3 concentration by both decreasing its biosynthe-
sis and increasing its metabolism (Hu, Shi, & Moe, 2019). 
FGF23 requires an additional cofactor, α-klotho, to bind with 
high affinity and signal efficiently through its cognate FGF 
receptors. Klotho and FGF receptors form a heterodimeric 
receptor for FGF23 (Urakawa et al., 2006). α-Klotho-mutant 
(kl/kl) mice exhibit blunted FGF23 signaling and increased 
Pi reabsorption, hyperphosphatemia, and ectopic calcification 
(Kuro-o et al., 1997; Segawa et al., 2007). Feeding kl/kl mice 
a low Pi diet can rescue the kl/kl mouse phenotype because 
renal klotho protein is upregulated in klotho-deficient animals 
(Morishita et al., 2001; Segawa et al., 2007). These findings 
suggest that kl/kl mice are not suitable for examining the ef-
fects of dietary Pi.
α-Klotho knockout (KLKO) mice have a phenotype similar 
to that of kl/kl mice (Alexander et al., 2009; Hu et al., 2019, 
2011; Kuro-o et al., 1997; Morishita et al., 2001; Ohnishi, 
Nakatani, Lanske, & Razzaque, 2009a, 2009b; Segawa et al., 
2007; Tsujikawa, Kurotaki, Fujimori, Fukuda, & Nabeshima, 
2003; Yoshida, Fujimori, & Nabeshima, 2002). A detailed anal-
ysis of Pi metabolism in KLKO mice has not yet been reported. 
Ohnishi et al reported that serum Pi levels are an important de-
terminant of calcification in α-klotho−/−/NaPi2a−/− mice, and 
lowering serum Pi levels can reduce or eliminate soft-tissue 
and vascular calcification, even in the presence of extremely 
high serum calcium (Ca) and active vitamin D levels (Ohnishi, 
Nakatani, Lanske, & Razzaque, 2009a).
In the present study, we investigated the role of Npt2c in 
KLKO mice. Our findings revealed that although Npt2c does 
not affect the plasma Pi concentration, it has the same effects 
as Npt2a to suppress calcification and increase the lifespan 
in KLKO mice.
2 |  MATERIAL AND METHODS
2.1 | Experimental animals
KLKO mice and Npt2aKO mice were purchased from 
CLEA Japan Inc. (Tokyo, Japan) and Jackson Laboratories, 
respectively. In the present study, we used KLKO mice 
produced by Tsujikawa et al. (2003). The generation of 
Npt2cKO mice was described previously (Segawa, Onitsuka, 
Kuwahata, et al., 2009). KLKO heterozygous mice and 
Npt2a or Npt2c heterozygous mice were crossed to generate 
KLKO (α-klotho−/−, Npt2a+/+, Npt2c+/+), α-klotho/Npt2a 
double KO (KL2aDKO; α-klotho−/−, Npt2a−/−, Npt2c+/+), 
and α-klotho/Npt2c double KO (KL2cDKO; α-klotho−/−, 
Npt2a+/+, Npt2c−/−) mice. Genomic DNA was extracted 
from tail clippings and amplified by polymerase chain re-
action (PCR) using the specific primers listed in Table 1. 
The mice were weaned at 3 weeks of age and were provided 
unlimited access to water and standard mouse chow (MF; 
Oriental). The mice were maintained under pathogen-free 
conditions and handled in accordance with the Guidelines 
for Animal Experimentation of Tokushima University 
School of Medicine (T29-3).
T A B L E  1  Primers for genotyping
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2.2 | Metabolic cages to collect urine and 
fecal samples
The mice were individually placed in metabolic cages at 
10:00  a.m. for quantitative urine and fecal collection for 
24 hr with free access to food and water. Fecal samples were 
ashed according to a modified protocol (Ikuta et al., 2019; 
Ikuta et al., 2018). The fecal samples were collected and 
placed in beakers and allowed to dry at 110°C for no more 
than 24 hr. The samples were then ashed at 250°C for 3 hr 
and at 550°C for 24 hr in a muffle furnace. The samples were 
cooled, weighed, and digested in HCl with heat, and the sam-
ple volume was standardized to 5 ml.
2.3 | Biochemical measurements
Plasma, urinary, and fecal Pi, and Ca were determined 
using commercial kits (Wako), respectively. Blood Ca2+ 
was analyzed using a Siemens Rapid Lab 348 Ca/pH ana-
lyzer. Concentrations of plasma FGF23, parathyroid hor-
mone (PTH), and 1,25(OH)2D3 were determined using the 
intact FGF23 ELISA kit (KAINOS Laboratories), intact PTH 
ELISA kit (Immunotopics Inc.), and 1,25-(OH)2 Vitamin D 
ELISA Kit (Immundiagnostik), respectively.
2.4 | RNA extraction and cDNA synthesis
Total RNA was extracted from mouse tissues using ISOGEN 
(Wako) according to the manufacturer's instructions. After 
treatment with DNase (Invitrogen), cDNA was synthe-
sized with or without the Moloney murine leukemia virus, 
reverse transcriptase (Invitrogen), and oligo(dT)12–18 
primer. Specific primers for NaPi transporters, Cyp27A1, 
Cyp24A1, IL-6, IL-1β, and GAPDH were used for the PCR 
reactions. The PCR primer sequences are shown in Table 
2. To check for genomic DNA contamination, a reverse 
transcriptase negative control experiment was performed 
(data not shown).
2.5 | Protein sample purification
Brush border membrane vesicles (BBMVs) were prepared 
from kidney and intestine using the Ca2+ precipitation 
method, and used for immunoblotting and Pi transport analy-
ses, as described previously (Furutani et al., 2013; Ikuta et 
al., 2018; Schlingmann et al., 2016).
2.6 | Transport assay
Transport of 32P into BBMVs was measured by the rapid fil-
tration technique as described previously (Ikuta et al., 2018; 
Segawa et al., 2004). The transport rate of Pi into the kidney 
BBMVs was determined at 30, 60 and 120 s at 25°C with an 
inward gradient of 100 mM NaCl or 100 mM KCl and 0.1 mM 
KH2PO4 (pH 7.5). The Na
+-dependent Pi transport activity 
(activity rate in the presence of Na+ in the absence of Na+) is 
shown. All measurements were performed in triplicate.
Intestinal absorption was assessed on the basis of the 32P 
blood level after gavage of a test solution using a previously 
described protocol with modifications (Matsuo et al., 2005; 
Van Cromphaut et al., 2001). The test solution (pH7.4) con-
tained 128 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM 
MgSO4, and 4 mM KH2PO4 (80 μCi/ml). For the study, 5 μl 
of the test solution per gram body weight was administered 
by gavage. Blood samples were obtained at the indicated 
time-points and analyzed by liquid scintillation counting.
T A B L E  2  Primers for RT-PCR
Name Sense primer sequences (5'-3') Anti sense primer sequence (5'-3')
1aOHase(qPCR) GAGCAAACTCCAGGAAGCAG TGAGGAATGATCAGGAGAGG
240Hase (qPCR) TGGGAAGATGATGGTGACCC TCGATGCAGGGCTTGACTG
Npt2a (qPCR) AGTCTCATTCGGATTTGGTGTCA GCCGATGGCCTCTACCCT
Npt2c (qPCR) TAATCTTCGCAGTTCAGGTTGCT CAGTGGAATTGGCAGTCTCAA
Npt2c (semi-quantitative PCR) AGGTCCCCAACCCTACTCTG TGCCTAGTAGCTGGAAAGCA
Npt2b (qPCR) CCTGGGACCTGCCTGAACT AATGCAGAGCGTCTTCCCTTT
PiT1 (qPCR) CCCATGGACCTGAAGGAGGA GCCACTGGAGTTGATCTGGT
PiT2 (qPCR) CTCAGAAGGCACGTCAGCAG AAACGTGACCGTCATTCCTC
IL-6 (qPCR) CACAAGTCCGGAGAGGAGAC TTGCCATTGCACAACTCTTT
IL-lb(qPCR) TGCCACCTTTT GACAGTGATG ATGTGCTGCTGCGAGATTTG
GAPDH (qPCR) CTGCACCACCAACTGCTTAGC CATCCACAGTCTTCTGGGTG
GAPDH (semi-quantitative PCR) i CTGCACCACCAACTGCTTAGC GCCTGCTTCACCACCTTCTTG
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2.7 | Immunoblotting
Protein samples were heated at 95°C for 5  min in sample 
buffer in the presence of 2-mercaptoethanol and subjected to 
8% sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis. The separated proteins were transferred by electrophore-
sis to Immobilon-P polyvinylidene difluoride (Millipore) and 
treated with diluted antibodies. Signals were detected using 
Immobilon Western (Millipore).
2.8 | Immunofluorescence staining
Mouse kidneys were fixed with the 4% paraformaldehyde 
solution (pH 7.2) overnight at 4°C, washed with phosphate 
buffered saline (PBS), cryoprotected with 10% and 20% su-
crose at 4°C, embedded in OCT compound (Miles), and fro-
zen in hexane at −80°C. Frozen sections (5 μm thick) were 
collected onto MAS-coated slides (Matsunami Glass IND, 
Ltd.) and air-dried (Ohkido, Segawa, Yanagida, Nakamura, 
& Miyamoto, 2003; Segawa et al., 2005). Serial sections were 
incubated with primary antibodies overnight at 4°C. Alexa 
Fluor 488 anti-rabbit (Molecular Probes) and Alexa Fluor 568 
anti-mouse (Molecular Probes) were used as secondary anti-
bodies for 60 min at room temperature. Thereafter, the sec-
tions were mounted with Dapi Fluoromount GTM (Southern 
Biotech).
2.9 | Antibodies
Rabbit anti-Npt2a and Npt2c polyclonal antibodies were gen-
erated as described previously and used for immunoblotting 
and immunohistochemistry (Ohkido et al., 2003; Segawa et 
al., 2005). Mouse anti-actin monoclonal antibody (Millipore) 
was used as an internal control. Horseradish peroxidase (HRP)-
conjugated anti-rabbit or anti-mouse IgG was utilized as the 
secondary antibody (Jackson Immuno Research Laboratories, 
Inc, West Grove, PA, USA). The diluted antibodies for im-
munoblotting were as follows: anti-Npt2a (1:15,000), -Npt2c 
(1:1,500), and -actin (1:10,000). The diluted antibodies for im-
munofluorescence staining were as follows: anti-Npt2a (1:500), 
-Npt2c (1:1,000), and -villin (Millipore) (1:500).
2.10 | Histologic analysis
Mouse tissues were fixed with 4% paraformaldehyde over-
night at 4°C and embedded in paraffin. Serial sections (5 µm 
thick) of several tissues were mounted on MAS-coated slides 
(Matsunami Glass IND, Ltd.). The sections were treated for 
hematoxylin and von Kossa staining prior to light microscopic 
observations. The von Kossa staining for mineral deposits 
was performed by applying 5% silver nitrate to the sections 
and exposing them to bright light for 30 min (Schlingmann 
et al., 2016). The sections were slightly counterstained with 
hematoxylin.
2.11 | Bone analysis
The femurs of all groups were fixed with 4% paraformal-
dehyde overnight at 4°C, decalcified for 4 weeks with 10% 
EDTA, and then, embedded into paraffin for immunohisto-
chemical examinations. For von Kossa staining, tibiae were 
immersed in a mixture containing 2% paraformaldehyde and 
2.5% glutaraldehyde diluted in a 0.067 M cacodylate buffer 
(pH 7.4) and post-fixed with 1% osmium tetraoxide in a 
0.067 M cacodylate buffer for 4 hr at 4°C. After post-fixation, 
the tibiae were embedded in epoxy resin (Epon 812, Taab, 
Berkshire, UK) and sliced at a 500 nm thickness using by an 
ultramicrotome.
Immunohistochemical analyses of mouse bone sec-
tions were performed as described previously. Briefly, 
the sections were immersed into 0.3% H2O2 in methanol 
for 30  min to block endogenous peroxidase. To reduce 
nonspecific binding, 1% bovine serum albumin (BSA; 
Serologicals Proteins Inc.) in PBS (1% BSA-PBS) was 
applied to the sections for 20  min. The sections were 
then incubated with rabbit polyclonal antisera against 
tissue-nonspecific alkaline phosphatase (ALP) (Oda et 
al., 1999). We rapidly purified soluble forms of glyco-
sylphosphatidylinositol-anchored proteins using human 
tissue-nonspecific ALP, or rabbit polyclonal anti-dentin 
matrix protein-1 (DMP-1; Takara Bio) with 1% BSA-PBS 
at room temperature for 2 hr as previously described, with 
some modifications (Oda et al., 1999). The thus treated 
sections were incubated with HRP-conjugated anti-rabbit 
F I G U R E  1  Physiologic analysis, renal phosphate transport, and transporter expression in KLKO mice. (a) Serum fibroblast growth factor 
(FGF)23, (b) plasma 1,25(OH)2D3, (c) plasma parathyroid hormone (PTH), (d) blood ionized Ca, (e) plasma Pi, (f) urinary Ca, and (g) urinary Pi 
excretion. Male mice at 8-weeks of age (n = 5–20) were used. Values are mean ± SE. *p < .05, **p < .01. Metabolic cages were used for 24-hr 
collection of urine from mice. (h) Renal Na+-dependent and (i) -independent Pi transport activity in renal BBMVs isolated from the kidneys of 
8-week-old WT and KLKO mice. Values are mean ± SE. *p < .05. (j) Western blot analysis of renal BBMVs isolated from the kidneys of 8-week-
old WT and KLKO mice (n = 3–5). Each lane was loaded with 20 μg of BBMVs. Actin was used as an internal control. Relative intensity of Npt2a 
and Npt2c expression in WT mice was defined as 1.0. Values are mean relative intensity ± SE. **p < .01 versus WT mice. (k) Immunofluorescence 
staining of DAPI (blue), villin (red), and Npt2a or Npt2c (green) in kidney sections of 8-week-old WT and KLKO mice. Sections were prepared 
from kidneys embedded in OCT compound and frozen. Scale bar; 100 μm
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antibody (Chemicon International, Temecula) for l hr, and 
thereafter, the immunoreactivities were visualized by using 
diaminobenzidine tetrahydrochloride as a chromogen.
For double detection of ALP and tartrate-resistant acid 
phosphatase (TRAP), the sections immunostained for ALP 
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phosphate (MilliporeSigma), 70  mg of red violet LB salt 
(MilliporeSigma), and 50  mM L(+) tartaric acid (0.76  g; 
Nacalai Tesque) diluted in 60 ml of a 0.1 M sodium acetate 
buffer (pH 5.0) for 20 min at room temperature. Methyl green 
was used to counterstain in all sections.
2.12 | Statistical analysis
Data are expressed as means ± SE. Differences among mul-
tiple groups were analyzed by ANOVA. The significance of 
differences between the two experimental groups was estab-
lished by ANOVA followed by Student's t-test. A p value of 
less than .05 was considered significant.
3 |  RESULTS
3.1 | Physiologic analysis, renal phosphate 
transport, and transporter expression in 
KLKO mice
The phenotypes of the KLKO mice were confirmed at 8 weeks 
of age (Figure 1). Compared with Klotho+/+ (WT) mice, 
KLKO mice exhibited high plasma concentrations of FGF23 
and 1,25(OH)2D3, hyperphosphatemia, and hypercalciuria, 
but not ionized Ca or PTH, as described previously (Figure 
1a–f) (Ohnishi et al., 2009a). Urinary Pi excretion was sig-
nificantly lower in KLKO mice than in WT mice (Figure 1g).
Renal Na+-dependent Pi transport activities were sig-
nificantly higher in KLKO mice than in WT mice (Figure 
1h). Na+-independent Pi transport activities did not differ 
between WT and KLKO mice (Figure 1i). Npt2a protein ex-
pression levels did not differ significantly between WT and 
KLKO mice (Figure 1j). In contrast, Npt2c protein expres-
sion levels were significantly higher in KLKO mice than in 
WT mice (Figure 1j). Npt2a and Npt2c protein expression 
was confirmed by immunofluorescence staining (Figure 
1k). Npt2a and Npt2c mRNA levels were not significantly 
different between WT and KLKO mice (Figure S1).
3.2 | Biochemical analysis of 
KL2cDKO mice
Feeding of a low Pi diet can rescue the kl/kl mouse phe-
notype (Morishita et al., 2001; Segawa et al., 2007). In the 
present study, we confirmed the effects of a low Pi diet on 
KLKO mice (Figure S2). KLKO mice were fed a low Pi diet 
from 8 weeks of age. A low Pi diet increased the body weight 
and extended the lifespan of KLKO mice, similar to that of 
kl/kl mice (Figure S2a). After 8 days, a low Pi diet signifi-
cantly decreased plasma Pi levels in KLKO mice compared 
with baseline levels before starting the test diet (Figure S2b).
To clarify the role of Npt2c in hyperphosphatemia in KLKO 
mice, we generated α-klotho−/−Npt2c−/− (KL2cDKO) mice 
for comparison with the α-klotho−/−Npt2a−/− (KL2aDKO) 
mice (Figure 2). Disruption of Npt2c in KLKO mice ex-
tended the lifespan of the KLKO mice (Figure 2a). KLKO 
mice had a significantly lower body weight than WT mice 
(p  <  .01 versus 4–14-week-old WT mice). KL2aDKO and 
KL2cDKO mice also had significantly lower body weights 
than WT mice (KL2aDKO; p < .01 versus 3–20-week-old WT 
mice, KL2cDKO; p < .05 versus 4–20-week-old WT mice). 
KL2aDKO and KL2cDKO mice had significantly greater 
body weights, however, than KLKO mice (KL2aDKO or 
KL2cDKO; p < .05 versus 12-week-old KLKO mice Figure 
2b). The body weight gain was similar between KL2aDKO 
and KL2cDKO mice (Figure 2b).
Plasma FGF23, 1,25(OH)2D3, and Pi levels, and urinary 
Pi excretion levels of the mice at 8 weeks of age are shown 
in Figure 2c–f. The phenotypes of the KL2aDKO mice were 
consistent with the previous description (Ohnishi et al., 2009a). 
Plasma FGF23 levels were also high in KL2cDKO mice, 
similar to KLKO and KL2aDKO mice (Figure 2c). KLKO, 
KL2aDKO, Npt2aKO, and KL2cDKO mice had higher levels 
of 1,25(OH)2D3 than WT mice (Figure 2d). Real-time PCR of 
renal 1αOHase and 24OHase mRNA was performed (Figure 
S3). The 1αOHase mRNA levels were significantly higher 
in KLKO, KL2aDKO, Npt2aKO, and KL2cDKO mice than 
in WT mice (Figure S3). In contrast, 24OHase mRNA levels 
were lower in KLKO, KL2aDKO, Npt2aKO, KL2cDKO, and 
Npt2cKO mice than in WT mice (Figure S3b). KL2aDKO mice 
had significantly lower plasma Pi levels than KLKO mice, as 
described previously (Figure 2e) (Ohnishi, Kato, Akiyoshi, 
Atfi, & Razzaque, 2011). The plasma Pi levels remained high 
in KL2cDKO mice, similar to that in KLKO mice (Figure 2f). 
Ohnishi et al. (2009a) did not measure urinary Pi excretion 
levels. In the present study, we measured urinary Pi excretion 
using metabolic cages. KL2aDKO mice had much higher 
urinary Pi excretion levels compared with the other groups 
of mice (Figure 2f). Urinary Pi excretion levels were signifi-
cantly higher in KL2cDKO mice than in KLKO mice (Figure 
2f). Hypercalcemia and hypercalciuria were also more severe 
F I G U R E  2  Characteristics of klotho/Npt2c double-KO (KL2cDKO) mice at 8 weeks of age. 8-week-old male WT, KLKO, klotho/Npt2c 
double KO (KL2cDKO), and Npt2cKO mice. (a) Survival rates and (b) Growth curves for WT, KLKO, klotho/Npt2a double KO (KL2aDKO), 
Npt2aKO, KL2cDKO, and Npt2cKO mice. Body weight was measured every week. (c–f) (c) Plasma FGF23 (d) 1,25(OH)2D3, (e) Pi, and (f) 
urinary Pi excretion. Male mice at 8 weeks of age (n = 5–70) were used. Values are mean ± SE. #p < .05, #′p < .01 versus WT mice, ap < .05, 
a′p < .01 versus KLKO mice, bp < .05, b′p < .01 versus KL2aDKO mice, cp < .05 versus Npt2aKO mice, and dp < .05 versus KL2cDKO mice
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in KL2aDKO mice compared with KLKO mice and the other 
mouse groups (Figure S3c and d). KL2cDKO mice did not ex-
hibit hypercalcemia, but had higher levels of urinary Ca excre-
tion compared with WT mice (Figure S3c and d). Urinary Ca 
excretion levels were not significantly different between KLKO 
and KL2cDKO mice (Figure S3c and d).
3.3 | Disruption of Npt2c in KLKO mice 
recovered renal and vascular calcification
Renal and vascular calcification was observed in KLKO mice 
at 8 weeks of age (Figure 3b, f and j), but not in WT (Figure 
3a, e and i) and Npt2cKO (Figure 3d, h and l) mice on the 
basis of von Kossa staining, as described previously (Segawa, 
Onitsuka, Kuwahata, et al., 2009). Disruption of Npt2c in 
KLKO mice at 8 weeks of age abolished the renal and vascular 
calcification (Figure 3c, g and k). The kidneys and arteries of 
elderly mice were evaluated with von Kossa staining (Figure 
3m–r). Plasma Pi levels of 40-week-old KL2cDKO mice also 
showed hyperphosphatemia (Plasma Pi concentration WT 
7.36 ± 0.48 mg/dl, KL2cDKO 12.4 ± 0.75, Npt2c 7.49 ± 0.52, 
n = 4–8). No renal and vascular calcification, however, was 
observed in 40-week-old KL2cDKO mice (Figure 3n and q).
3.4 | Npt2c plays an important role in 
KLKO mice during the juvenile period
Because Npt2c is highly expressed during the juvenile period, 
we previously reported that Npt2c is a growth-related Pi trans-
porter (Ohkido et al., 2003; Segawa et al., 2002). KLKO mice 
F I G U R E  3  Disruption of ectopic 
calcification in KL2cDKO mice. The von 
Kossa staining of kidney (a–h, m–o) and 
aorta (i–l, p–r) sections from WT, KLKO, 
KL2cDKO, and Npt2cKO mice. Kidney 
and aorta sections were prepared from 
paraffin-embedded tissues of 8-week-old 
(a–h, i–l) and 40-week-old mice (m–o, 
p–r), respectively. Counterstaining with 
hematoxylin is shown. White arrowheads 
indicate mineral deposits. Magnification; 
×40 (a–d, m–o), ×200 (e–l, p–r)
WT KLKO KL2cDKO Npt2cKO
e f g h
a b c d
i j k l
m n o
p q r
F I G U R E  4  Characteristics of klotho/Npt2c double-KO (KL2cDKO) mice at 5 weeks of age. (a) Plasma Pi and (b) urinary Pi excretion 
levels of 5-week-old WT and KLKO mice (n = 5–15). Values are mean ± SE. *p < .05. (c) Western blot analysis of renal BBMVs isolated from 
the kidneys of 5-week-old WT and KLKO mice (n = 5, respectively). Each lane was loaded with 20 μg of BBMVs. Actin was used as an internal 
control. Relative intensity of Npt2a and Npt2c expression in WT mice. Values are mean ± SE. *p < .05. (d) Immunofluorescence staining of Npt2a 
or Npt2c (green) in renal sections of 5-week-old WT and KLKO mice. DAPI (blue), villin (red). Sections were prepared from kidneys embedded 
in OCT compound and frozen. Scale bar; 100 μm. (e) Plasma Pi and (f) urinary Pi excretion, and (g) 1,25(OH)2D3 of 5-week-old mice (n = 5–9). 
Values are mean ± SE. #p < .05, #′p < .01 versus WT mice, ap < .05 versus, a'p < .01 versus KLKO mice, bp < .05 versus KL2aDKO mice, 
cp < .05 versus Npt2aKO mice, and dp < .05 versus KL2cDKO mice. (h) Interleukin (IL)-6 and (i) IL-1β mRNA levels in the kidney by real-time 
PCR analysis. Male mice at 5 weeks of age (n = 5–9) were used. GAPDH was used as an internal control. Relative intensity of Npt2a and Npt2c 
expression in WT mice was defined as 1.0. Values are mean ± SE. #′p < .01 versus WT mice, ap < .05 versus, a'p < .01 versus KLKO mice
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at 5 weeks of age showed hyperphosphatemia and hypercalciu-
ria, but not hyperphosphaturia or hypercalcemia (Figure 4a and 
b, and Figure S4a and b). The Npt2a protein expression levels 
were significantly lower in 5-week-old KLKO mice compared 
with WT mice (Figure 4c). In contrast, the Npt2c protein ex-
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mice compared with WT mice (Figure 4c). Furthermore, Npt2a 
and Npt2c protein expression in 5-week-old KLKO mice was 
confirmed by immunofluorescence staining (Figure 4d). Npt2a 
mRNA levels were significantly lower in KLKO mice than in 
WT mice at 5 weeks of age (Figure S4c). Npt2c mRNA levels, 
however, were not different between WT and KLKO mice at 
5 weeks of age (Figure S4c).
Disruption of Npt2c in KLKO mice at 5  weeks of age 
significantly decreased the plasma Pi levels compared with 
KLKO mice, but plasma Pi levels were significantly higher 
in KL2cDKO mice than in WT and Npt2cKO mice (Figure 
4e). Urinary Pi excretion did not differ significantly among 
groups (Figure 4f). Furthermore, KL2aDKO and Npt2aKO 
mice exhibited hypercalcemia and hypercalciuria compared 
with the other mouse groups (Figure S4d and e). KL2cDKO 
mice had slight, but significant hypercalcemia compared 
with WT and KLKO mice (Figure S4d). Furthermore, 
KL2cDKO mice had hypercalciuria compared with WT 
mice, but were not different from KLKO mice (Figure S4e). 
KL2aDKO and KL2cDKO mice at 5 weeks of age had higher 
1,25(OH)2D3 levels than WT mice (Figure 4g). Furthermore, 
the 1,25(OH)2D3 levels were significantly suppressed in 
KL2aDKO mice, but not in KL2cDKO mice compared with 
KLKO mice (Figure 4g).
Real-time PCR of renal 1αOHase and 24OHase mRNA 
was performed (Figure S4f and g). The 1αOHase mRNA 
levels tended to be higher in KLKO, KL2aDKO, Npt2aKO, 
and KL2cDKO mice than in WT mice (Figure S4f). In con-
trast, 24OHase mRNA levels tended to be lower in KLKO, 
KL2aDKO, Npt2aKO, KL2cDKO, and Npt2cKO mice than 
in WT mice (Figure S4g). Real-time PCR on inflammation 
markers, interleukin (IL)-6 and IL-1β, are shown in Figure 4h 
and i. Disruption of Npt2c in KLKO mice significantly de-
creased the IL-6 and IL-1β mRNA levels to those in KLKO 
mice (Figure 4f and g).
3.5 | Bone histochemical analysis
Bone histochemical analysis was performed in 5-week-old 
mice (Figure 5). The bone volume of the femoral metaphy-
ses in Npt2aKO and KL2aDKO mice seemed to be markedly 
reduced, while those in KLKO, Npt2cKO, and KL2cDKO 
mice appeared to be similar or slightly decreased compared 
with that in WT mice (Figure 5A–L).
Von Kossa staining to evaluate the metaphyseal mineraliza-
tion in Npt2aKO and KL2aDKO mice revealed markedly re-
duced metaphyseal trabeculae in both groups (Figure 5O, P, c, 
d). Npt2aKO mice exhibited the broad areas of unmineralized 
bone matrix in the metaphyses, while KL2aDKO mice showed 
only slightly unmineralized bone matrix in the corresponding 
areas, indicating that bone mineralization of KL2aDKO mice 
seemed to have recovered to some extent by Npt2a deficiency 
(Figure 5O, P, c, d). Unlike Npt2aKO mice, mineralization in 
metaphyseal trabeculae was similar between Npt2cKO mice 
and WT mice (Figure 5M, R, a, f). Despite a similar metaphy-
seal bone volume as in WT, KLKO and KL2cDKO mice exhib-
ited very large of unmineralized bone matrix compared with the 
WT mice (Figure 5M, N, Q, a, b, e).
Histologically assessment by double immunostaining 
for ALP/TRAP revealed similar numbers of ALP-positive 
osteoblasts and TRAP-reactive osteoclasts in all the groups 
(Figure 5g–l). Interestingly, an intense accumulation of 
DMP-1 immunoreactivity was observed in the osteocyte la-
cunae of KLKO and KL2cDKO mice (Figure 5n and q). In 
contrast, Npt2aKO, KL2aDKO, and Npt2cKO mice showed 
a distribution pattern of DMP-1 immunoreactivity in the os-
teocytic lacunar-canalicular system that was similar to that of 
WT mice (Figure 5m, o, p, r).
3.6 | Intestinal Pi absorption in 
KL2cDKO mice
Intestinal Pi absorption in KLKO mice has not been studied in 
detail. KLKO mice may have increased intestinal Pi absorp-
tion due to the high plasma vitamin D levels. The high vitamin 
D levels may also contribute to hyperphosphatemia in KLKO 
mice. Fecal Pi excretion was measured in juvenile (5-week-
old) and adult KLKO (8-week-old) mice using metabolic cages 
(Figure 6a–d). In the juvenile period, KLKO, KL2cDKO, and 
Npt2cKO mice had higher food intake (mg/g body weight) 
than WT mice, but there was no difference in fecal Pi excretion 
(Figure 6a and b). In adults, food intake (mg/g body weight) did 
not differ between groups, but fecal Pi excretion was signifi-
cantly lower in KLKO mice compared with WT mice (Figure 
6c and d). Disruption of Npt2c in 8-week-old KLKO mice, 
however, recovered the fecal Pi excretion level compared with 
8-week-old KLKO mice (Figure 6d). Furthermore, to confirm 
the intestinal Pi absorption, 32P was administered orally and the 
Pi absorption rate was measured at 8 weeks of age (Figure 6e). 
The Pi absorption rates (32P transfer from intestine to the blood) 
were significantly increased in KLKO mice compared with WT 
mice (Figure 6e). Disruption of Npt2c in 8-week-old KLKO 
mice significantly decreased the Pi absorption rate compared 
with KLKO mice (Figure 6e).
Next, we investigated the reasons for the suppression of 
fecal Pi excretion in KL2cDKO mice compared with KLKO 
mice. Npt2c is mainly expressed in the kidney (Ohkido et al., 
2003; Segawa et al., 2002). In the present study, we evaluated 
Npt2c in the mouse intestine. Npt2c mRNA expression was 
detected in the proximal and distal mouse intestine (Figure 
6f). Furthermore, intestinal Npt2c mRNA expression levels 
were significantly increased in 8-week-old KLKO mice, but 
not in 5-week-old KLKO mice, compared with WT mice 
(Figure 6g).
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Intestinal Pi transporter mRNA expression is shown in 
Figure 7. Intestinal PiT1 and PiT2 mRNA levels were sig-
nificantly increased in KLKO mice compared with WT mice 
(Figure 7a and b). Intestinal Npt2b mRNA levels were not 
different in KLKO mice compared with WT mice (Figure 
7c). Disruption of Npt2c in KLKO mice suppressed the in-
duction of PiT1 and PiT2 mRNA (Figure 7a and b).
3.7 | Role of Npt2c in controlling blood Pi 
levels in juvenile mice
Finally, we confirmed renal Npt2a and Npt2c protein ex-
pression around the juvenile period (Figure S5a and b). As 
described previously, Npt2a protein expression gradually in-
creased with growth (Figure S5a and b). In contrast, Npt2c 
protein expression rapidly increased at 28 days of age (28D; 
Figure S5a and b). PTH and FGF23 levels were measured in 
mice at 15, 21, 28, and 60 days (Figure S5c and d). Plasma 
PTH levels in mice at 21, 28, and 60 days were significantly 
lower than those at 15 days (Figure S5c). In contrast, FGF23 
levels in mice were lower at 21 and 28 days than at 15 and 
60 days (Figure S5d). Next, we measured plasma Pi levels in 
juvenile Npt2cKO mice (Figure 8). In juvenile Npt2cKO mice, 
plasma Pi levels began to decrease around 15 days of age and 
showed significant hypophosphatemia at 21 days (Figure 8).
4 |  DISCUSSION
In the present study, to investigate the roles of Npt2c on 
FGF23/klotho signals in Pi homeostasis, we evaluated the 
KL2cDKO mouse phenotype. High plasma 1,25(OH)2D3 
levels in KLKO mice may contribute to hyperphosphatemia 
by enhancing intestinal Pi absorption and renal Pi reabsorp-
tion. KLKO mice exhibited increased renal Npt2c protein 
levels. These phenotypes were also observed in kl/kl mice, 
but both Npt2a and Npt2c were increased in the kl/kl mice. 
The KLKO mouse phenotypes were similar to those de-
scribed in several previous studies (Alexander et al., 2009; 
Hu et al., 2019, 2011; Kuro-o et al., 1997; Morishita et al., 
2001; Ohnishi et al., 2009a; Ohnishi, Nakatani, Lanske, & 
Razzaque, 2009b; Segawa et al., 2007; Tsujikawa et al., 
2003; Yoshida et al., 2002).
The lifespan of both KL2aDKO and KL2cDKO mice 
was significantly extended compared with that of KLKO 
mice. In KL2aDKO mice, despite the increased plasma 
1,25(OH)2D3 levels, we predicted that the increased renal 
F I G U R E  5  Bone analysis. Histologic 
analysis of longitudinal femoral sections 
from 5-week-old WT, KLKO, KL2aDKO, 
Npt2a, KL2cDKO, and Npt2cKO mice. 
(A–F) Hematoxylin/eosin (H-E) staining of 
distal femurs in 5-week-old mice. Scale bar 
300 μm. (G–L) Higher magnified images of 
distal metaphysis from H-E staining. Scale 
bar; 100 μm. (M–R) Von Kossa staining 
(black) of metaphyseal trabeculae. Scale 
bar 30 μm. (a–f) Higher magnified images 
of von Kossa staining of metaphyseal 
trabeculae. Scale bar 20 μm. (g–l) 
Double staining of alkaline phosphatase 
(ALP, brown color) and tartrate-resistant 
acid phosphatase (TRAP, red color) of 
metaphyseal trabeculae. Scale bar 30 μm. 
(m–r) Immunohistochemistry of DMP-1 
(brown color) in metaphyseal trabeculae. 
Scale bar 20 μm
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Pi loss would reduce Pi toxicity and extend the lifespan, as 
well as improve soft-tissue and vascular calcification com-
pared with KLKO mice. In the present study, a low Pi-diet 
prolonged the lifespan of KLKO mice. These observations 
are consistent with the reported phenotypes of KL2aDKO 
mice (Ohnishi et al., 2009a). In KL2aDKO mice, serum 
Pi levels are an important determinant of calcification 
and lowering serum Pi levels can reduce or eliminate 
F I G U R E  6  Disruption of Npt2c suppressed intestinal Pi absorption in KLKO mice. Food intake (a and c) and fecal Pi excretion (b and d). 
Metabolic cages were used for measurement of 24-hr food intake (mg/g body weight [BW]), and collection of feces from mice (n = 5–9). Values 
are mean ± SE. #p < .05, #′p < .01 versus WT mice, ap < .05 versus KLKO mice. (e) Intestinal phosphate absorption assays in 8-week-old WT, 
KLKO, and KL2cDKO mice. Change in the blood Pi at 4 and 60 min after administration of the 32P test solution. Relative rate of 32P absorption in 
WT mice was defined as 100%. Values are mean ± SE, #′p < .01, a'p < .01, n = 3–4. (f) Npt2c mRNA in the kidney, proximal and distal intestine of 
WT mice. (g) Real-time PCR analysis for Npt2c mRNA in the proximal and distal intestine of male WT and KLKO mice (n = 5–9). GAPDH was 
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soft-tissue and vascular calcification, even in the presence 
of extremely high serum Ca and 1,25(OH)2D3 levels com-
pared with KLKO mice.
Survival curves indicated that the lifespan of KL2cDKO 
mice was extended similarly to that of KL2aDKO mice 
compared with KLKO mice. The plasma Pi levels in adult 
KL2cDKO mice (8-week-old) did not decrease, however, 
and plasma 1,25(OH)2D3 levels also remained high. Renal 
Pi excretion was significantly increased in KL2cDKO mice 
compared with KLKO mice. In addition, adult (8-week-
old) KLKO mice had significantly decreased fecal Pi ex-
cretion, and increased the levels of intestinal PiT1, PiT2, 
and Npt2c mRNA compared with WT mice. In vivo 32P 
oral administration, to KL2cDKO mice significantly sup-
pressed intestinal Pi absorption compared with that in the 
KLKO mice. Thus, in KL2cDKO mice, although there was 
no change in the plasma Pi concentration, the body Pi load 
was reduced by increased intestinal and renal Pi excretion 
compared with that in KLKO mice. Such changes are ex-
pected to result in the suppression of calcification (kidney 
and aorta).
On the other hand, plasma Pi levels were reduced in 
5-week-old KL2cDKO mice compared with KLKO mice. 
Renal Npt2c is specifically increased during the juvenile 
F I G U R E  7  Intestinal Pi transporter 
in 8-week-old KL2cDKO mice. (a) PiT1, 
(b) PiT2, and (c) Npt2b mRNA levels in the 
proximal and distal intestine by real-time 
PCR analysis. Male mice at 8 weeks of age 
(n = 5–9) were used. GAPDH was used 
as an internal control. Relative intensity 
of transporter expression in WT mice was 
defined as 1.0. Values are mean ± SE. 













































































































































































































































F I G U R E  8  Npt2cKO mice had hypophosphatemia in the 
juvenile period. Plasma Pi concentration in WT and Npt2cKO 
mice at 1, 5, 10, 15, 21, and 28 days of age (n = 10–30). Values are 
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period, suggesting that Npt2c function is involved in renal Pi 
reabsorption. Urinary Pi excretion levels, however, were not 
altered in 5-week-old KL2cDKO mice compared with KLKO 
mice. Furthermore, previous and current data revealed no 
change in Pi excretion in 5-week-old Npt2cKO mice. We pre-
dicted that organs other than the kidney that express Npt2c 
contribute to the decreased plasma Pi concentration.
Deletion of Npt2c in KLKO mice did not have a clear re-
covery effect on bone phenotype. In addition, bone abnor-
malities in KLKO mice may have been caused by factors such 
as increased FGF23 due to klotho deficiency rather than sup-
pression of plasma Pi levels, as described previously (Hikone 
et al., 2017).
Previous analyses of Npt2cKO mice (4 and 8  weeks 
of age) showed no clear abnormalities in Pi metabolism 
(Segawa, Onitsuka, Kuwahata, et al., 2009). Therefore, the 
role of Npt2c in the pathogenesis of HHRH due to Npt2c 
abnormalities is unclear in mice. We examined plasma Pi 
levels in Npt2cKO mice before weaning. Npt2cKO mice ex-
hibited a significant decrease in plasma Pi levels at 21 days 
of age. We expect that Npt2c maintains postnatal plasma 
Pi levels. During the time when Npt2c is considered im-
portant, we evaluated the FGF23 and PTH concentrations, 
and found that FGF23 concentrations were significantly 
decreased. Changes in the plasma FGF23 levels may also 
play an important role in the induction of postnatal Npt2c 
protein.
The difference in the role of NaPi-2c in humans and 
mice is not well understood. On the basis of our findings, 
mouse NaPi-2c is necessary for increasing plasma Pi lev-
els during the growth phase. In the mature period, it con-
tributes to the absorption/excretion of Pi in the intestine/
kidney rather than maintenance of the plasma Pi concen-
tration, suggesting that it is involved in the retention of Pi 
in the body. On the other hand, human NaPi-2c, like mouse 
NaPi-2a, is expected to be an important molecule for main-
taining plasma Pi levels. Although patients with HHRH 
typically present in childhood with rickets and/or nephro-
lithiasis, patients occasionally present as adults with low 
bone density (Dasgupta et al., 2014; Dhir, Li, Hakonarson, 
& Levine, 2017). NaPi-2c may have different roles in the 
body depending on age.
Finally, Npt2c may contribute to maintaining plasma Pi 
levels for growth during the juvenile period and may also be 
important for Pi retention in adults by controlling intestinal 
and renal Pi absorption. Figure 9 summarizes the KLKO, 
KL2aDKO, and KL2cDKO mouse phenotypes. Analysis of 
mouse NaPi-2c may be useful toward understanding the role 
of NaPi-2c in phenotypically different HHRH patients.
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